NYXOAH SA - ORDINARY SHARES

Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

29 июл 2024 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

15 июл 2024 02:00:00 Источник Nasdaq GlobeNewswire

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

03 июл 2024 06:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

01 июл 2024 02:00:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

28 июн 2024 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Jefferies Global Healthcare Conference

03 июн 2024 16:30:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

03 июн 2024 16:15:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

03 июн 2024 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

31 май 2024 02:00:00 Источник Nasdaq GlobeNewswire

Information on the Total Number of Voting Rights and Shares

28 май 2024 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Pricing of Offering

23 май 2024 09:59:25 Источник Nasdaq GlobeNewswire

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

22 май 2024 16:10:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Proposed Offering of Ordinary Shares

22 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Reports First Quarter 2024 Financial and Operating Results

14 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

13 май 2024 16:30:00 Источник Nasdaq GlobeNewswire

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024

10 май 2024 01:00:00 Источник Nasdaq GlobeNewswire

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

11 апр 2024 16:30:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

29 мар 2024 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

25 мар 2024 02:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

19 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire